Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects

NCT06135363 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: SC1011
DRUG: Placebo tablet

Sponsor

Guangzhou JOYO Pharma Co., Ltd